﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2011v1.2">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2013-01-25T12:32:10-06:00</Timestamp>
    <TaxPeriodEndDate>2011-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <EIN>271728945</EIN>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>O'CONNOR DAVIES MUNNS AND DOBBINS LLP</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>665 FIFTH AVENUE</AddressLine1>
        <City>NEW YORK</City>
        <State>NY</State>
        <ZIPCode>10022</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2011-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>223419667</EIN>
      <Name>
        <BusinessNameLine1>INTERNATIONAL UNION AGAINST TUBERCULOSIS</BusinessNameLine1>
        <BusinessNameLine2>AND LUNG DISEASE INC</BusinessNameLine2>
      </Name>
      <NameControl>INTE</NameControl>
      <Phone>2125005724</Phone>
      <USAddress>
        <AddressLine1>61 BROADWAY NO 1720</AddressLine1>
        <City>NEW YORK</City>
        <State>NY</State>
        <ZIPCode>10006</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>JOSE LUIS CASTRO</Name>
      <Title>PRESIDENT</Title>
      <Phone>2125005724</Phone>
      <DateSigned>2013-01-18</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>GARRETT M HIGGINS</Name>
      <PTIN>P00543209</PTIN>
      <Phone>2122862600</Phone>
      <DatePrepared>2013-01-25</DatePrepared>
    </Preparer>
    <TaxYear>2011</TaxYear>
    <BuildTS>2016-03-07 17:11:31Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001 RetDoc2125800001">
      <NameOfPrincipalOfficerPerson>JOSE LUIS CASTRO</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>61 BROADWAY NO 1720</AddressLine1>
        <City>NEW YORK</City>
        <State>NY</State>
        <ZIPCode>10006</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>24926646</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.THEUNION.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1995</YearFormation>
      <StateLegalDomicile>NJ</StateLegalDomicile>
      <ActivityOrMissionDescription>IUATLD,INC. IS A FULLY REGISTERED NON-PROFIT, PUBLIC CHARITY ORGANIZATION BASED IN NEW YORK CITY AND SERVES AS THE NORTH AMERICAN AFFILIATE OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE (THE UNION), HEADQUARTERED IN PARIS, FRANCE. DURING TAX YEAR 2010 (JANUARY-DECEMBER 2010), THE ORGANIZATION UNDERTOOK SEVERAL MAJOR ACTIVITIES RELATED TO BOTH ORGANIZATIONAL DEVELOPMENT AND PROGRAMMATIC INITIATIVES. THIS STATEMENT DESCRIBES THE MAJOR ACTIVITIES UNDERTAKEN AND ACCOMPLISHMENTS ACHIEVED. TECHNICAL PROJECT ACTIVITY 1: DEVELOPING THE EVIDENCE BASE FOR DIAGNOSTIC TOOLSKEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. FINALIZATION AND DISSEMINATION OF THE REPORT AND RESEARCH AGENDA FROM GLOBAL CONSULTATION ON DIGITAL RADIOGRAPHY. THE TEAM ALSO CONDUCTED ADDITIONAL RESEARCH FOR AN OPINION PIECE, WHICH IS SCHEDULED TO BE SUBMITTED FOR PUBLICATION IN 2011.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>7</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>5</NbrIndependentVotingMembers>
      <TotalNbrEmployees>8</TotalNbrEmployees>
      <TotalNbrVolunteers>5</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>20284523</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>24925400</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>0</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>0</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>12005</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>1246</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>221</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>0</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>20296749</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>24926646</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>19009023</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>22613614</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>953244</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>765501</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>0</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>0</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>499175</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>641815</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>20461442</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>24020930</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>-164693</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>905716</RevenuesLessExpensesCY>
      <TotalAssetsBOY>2496697</TotalAssetsBOY>
      <TotalAssetsEOY>9564646</TotalAssetsEOY>
      <TotalLiabilitiesBOY>2570184</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>8732417</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>-73487</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>832229</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE UNION BRINGS INNOVATION, EXPERTISE, SOLUTIONS AND SUPPORT TO ADDRESS HEALTH CHALLENGES IN LOW AND MIDDLE INCOME POPULATIONS. OUR VISION IS TO DEVELOP HEALTH SOLUTIONS FOR THE POOR. OUR VALUES INCLUDE:1. QUALITY: WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST POSSIBLE STANDARDS.2. ACCOUNTABILITY: WE ARE RESPONSIBLE STEWARDS OF RESOURCES AND DELIVER ON OUR COMMITMENTS.3. INDEPENDENCE: WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION, AND ARE GUIDED BY THE BEST EVIDENCE TO IMPROVE THE HEALTH OF THE POOR4. SOLIDARITY: WE STAND TOGETHER AS ONE UNION TO OVERCOME THE GREATEST CHALLENGES TO IMPROVE HEALTH AMONG THE COMMUNITIES WE SERVE.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>2594382</Expense>
      <Grants>1959922</Grants>
      <Description>TREAT TB RESEARCH ACTIVITIES:PROVE-IT BACKGROUND MANY NEW DIAGNOSTIC TOOLS FOR TB HAVE EMERGED RECENTLY, BUT THEIR PERFORMANCE IN DIVERSE EPIDEMIOLOGICAL SETTINGS, HEALTH SYSTEM STRUCTURES AND PATIENT GROUPS REMAINS UNCLEAR. IN AN EFFORT TO OPTIMIZE THE SCALE-UP OF THESE NEW DIAGNOSTIC TOOLS, TREAT TB HAS DEVELOPED AN ASSESSMENT METHODOLOGY THAT MOVES BEYOND THE TRADITIONAL ACCURACY TESTS TO EVALUATE A TOOL'S IMPACT ON BOTH THE HEALTH SYSTEM AND PATIENTS. UTILIZING THIS INNOVATIVE APPROACH, TREAT TB IS EVALUATING LINE PROBE ASSAYS (LPA), A NEW DIAGNOSTIC TEST THAT MAY MAKE RAPID SCREENING FOR DRUG-RESISTANT TB POSSIBLE. THE NAME OF THIS STUDY IS PROVE-IT (POLICY RELEVANT OUTCOMES FROM VALIDATING EVIDENCE ON IMPACT) AND IT AIMS TO IDENTIFY THE COSTS ASSOCIATED WITH LPA TESTS, THE PREREQUISITE HEALTH SYSTEM REQUIREMENTS, AND THE IMPACT ON THE TIME BETWEEN DIAGNOSIS AND TREATMENT.IN 2011, THE PROVE IT STUDY WAS IMPLEMENTED IN ALL THREE COUNTRIES BRAZIL, RUSSIA, AND SOUTH AFRICA. THE KEY ACHIEVEMENTS INCLUDE:RECRUITMENT OF APPROXIMATELY 161 PATIENTS IN ARKHANGELSK, RUSSIA BY DECEMBER 2011. ENROLMENT OF A TOTAL OF 27 PATIENTS IN THE STUDY IN BRAZIL IN NOVEMBER - DECEMBER 2011 AS WELL AS THE INITIATION OF THE ECONOMIC IMPACT AND POLICY TRANSFER INTERVIEWS IN ALL FIVE SITES.COMPLETED MORE THAN 160 CASE REPORT FORMS (CRF) FOR THE PROVE IT STUDY IN SOUTH AFRICA IN 2011. THE CRFS ARE THE TOOL THE RESEARCH TEAM USES TO COLLECT PATIENT DATA AND ASSESS THEIR HEALTH OUTCOMES. THE SOUTH AFRICA TEAM ALSO CONDUCTED THE KEY STAKEHOLDER, ECONOMIC IMPACT, AND POLICY TRANSFER ANALYSIS INTERVIEWS.MODELLINGTHE TREAT TB MODELLING COLLABORATION FOR NEW DIAGNOSTIC TOOLS IS A COMPONENT OF THE TREAT TB DIAGNOSTIC TOOLS INITIATIVE. SEVERAL TECHNICAL PARTNERS HAVE WORKED TOGETHER TO CREATE A COMPREHENSIVE MODELLING APPROACH THAT OFFERS IMPROVED GUIDANCE TO MANAGERS AND POLICY-MAKERS IN HIGH-BURDEN COUNTRIES REGARDING THE PACKAGES OF DIAGNOSTIC TOOLS MOST SUITABLE FOR THEIR EPIDEMIOLOGICAL SETTINGS AS WELL AS THE HEALTH SYSTEM REQUIREMENTS ASSOCIATED WITH THE ADOPTION AND IMPLEMENTATION OF THESE TOOLS ON A LARGE SCALE. THE MODELLING TEAM PUBLISHED AN ARTICLE DESCRIBING THEIR MODELLING APPROACH IN THE AUGUST 2011 ISSUE OF THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE AND BEGAN TO REFINE THEIR MODELLING APPROACH TO ASSESS DRUG-RESISTANT TB WITH A PARTICULAR FOCUS ON THE ROLE OF XPERT MTB/RIF, A NEW DIAGNOSTIC TOOL THAT WAS RECENTLY RECOMMENDED BY THE WORLD HEALTH ORGANIZATION (WHO). THEY ARE ALSO WORKING WITH THE PROVE IT STUDY TEAM IN BRAZIL TO USE THIS MODELLING APPROACH TO EVALUATE THE IMPACT OF LINE PROBE ASSAYS AND OTHER NEW DIAGNOSTIC TOOLS CURRENTLY UNDER CONSIDERATION IN BRAZIL. STREAMTHE UNION'S EVALUATION OF A STANDARDISED TREATMENT REGIMEN OF ANTI-TUBERCULOSIS DRUGS FOR PATIENTS WITH MULTIPLE DRUG-RESISTANT TUBERCULOSIS OR STREAM WILL SEEK TO DETERMINE WHETHER A REGIMEN DEVELOPED AND IMPLEMENTED BY THE DAMIEN FOUNDATION AND THE INSTITUTE OF TROPICAL MEDICINE, AND USED WITH NOTABLE SUCCESS IN BANGLADESH, CAN BE UTILIZED IN DIFFERENT SETTINGS WITH COMPARABLE RESULTS.IN 2011, TREAT TB CONDUCTED THE FOLLOWING ACTIVITIES TO PREPARE FOR THE STREAM CLINICAL TRIAL:CONVENED A PROJECT MEETING WITH THE EXTENDED INTERNATIONAL RESEARCH TEAM AND LOCAL PARTNERS DURING THE 2011 WORLD CONFERENCE ON LUNG HEALTH IN LILLE, FRANCE TO FINALIZE OUTSTANDING IMPLEMENTATION ISSUES AND PLAN THE NEXT STEPS.HELD THE FIRST TRIAL STEERING COMMITTEE MEETING ON 30 OCTOBER IN LILLE, FRANCE.OBTAINED APPROVAL FROM SOUTH AFRICA'S MEDICAL CONTROL COUNCIL (MCC) FOR THEIR APPROVAL TO IMPORT THE STREAM REGIMEN AND IS CURRENTLY WORKING WITH THE LOCAL WORLD HEALTH. ORGANIZATION OFFICE TO PLAN THE DELIVERY OF THE STREAM MEDICINES TO THE PROPOSED SITES IN DURBAN AND JOHANNESBURG.CONVENED THE FIRST COMMUNITY ADVISORY BOARD (CAB) MEETING IN SOUTH AFRICA AND IDENTIFIED A POTENTIAL PARTNER FOR COMMUNITY ENGAGEMENT ACTIVITIES IN VIET NAM.MET WITH THE LOCAL RESEARCH TEAMS IN ADDIS ABABA, ETHIOPIA AND JOHANNESBURG, SOUTH AFRICA AS WELL AS THE LOCAL USAID OFFICES TO FINALIZE THE PLANS FOR STREAM IMPLEMENTATION IN ETHIOPIA AND SOUTH AFRICA.CONDUCTED A THOROUGH TRAINING SEMINAR FOR LAB PERSONNEL FROM ST. PETER'S HOSPITAL AND ARMAUER HANSEN RESEARCH INSTITUTE (AHRI) TO PROVIDE THEM WITH THE KNOWLEDGE THEY NEED TO SUCCESSFULLY USE THE LAB TECHNIQUES AND EQUIPMENT DESCRIBED IN THE STREAM PROTOCOL. CONTINUED TO DISCUSS THE STREAM STUDY WITH LOCAL PARTNERS IN NEW DELHI AND RESPONDED TO QUESTIONS ABOUT THE STUDY DESIGN FROM THE INTERNAL REVIEW BOARD OF THE TUBERCULOSIS RESEARCH CENTRE (TRC), ONE OF THE PROPOSED SITES IN INDIA. THE STREAM RESEARCH TEAM EXPECTS THE STUDY TO MOVE FORWARD ONCE THE TRC ISSUES ITS APPROVAL.</Description>
      <Activity2>
        <Expense>18739186</Expense>
        <Grants>18453122</Grants>
        <Description>TOBACCO CONTROL:SIGNIFICANT IMPACT WAS ACHIEVED IN POLICY AND LEGISLATION IN 2011, INCLUDING IN SEVERAL BI TOP-15 PRIORITY COUNTRIES, SUCH AS CHINA, RUSSIA, BRAZIL AND MEXICO, IN ADDITION TO A NUMBER OF OTHER COUNTRIES IN LATIN AMERICA AND NEPAL. IN CHINA, THE SMOKEFREE LEGISLATION APPROVED BY HARBIN'S PEOPLE'S CONGRESS HAS GIVEN HOPE FOR REPLICATION IN OTHER CITIES ACROSS THE COUNTRY,AS IT WAS DEEMED TO BE THE FIRST SUCH LEGISLATION IN LINE WITH ARTICLE 8 OF THE FCTC. THE UNION HAS BEEN FOLLOWING AND SUPPORTING THE RECENTLY RELEASED DRAFT LEGISLATION IN RUSSIA, WHICH IS A POSITIVE STEP TOWARDS FCTC COMPLIANCE. RUSSIA HAS ALSO BEEN ACTIVE ON GETTING TOBACCO CONTROL INTO THE BROADER HEALTH AGENDA, WITH CESSATIONS CLINICS OPENING IN KRASNODARSKY KRAI, WITH MORE EXPECTED TO OPEN IN 2012.ONE OF THE MOST NOTABLE EVENTS IN QUARTER 4 WAS THE ANNOUNCEMENT BY THE BRAZILIAN SENATE APPROVING A NATION-WIDE LAW BANNING SMOKING IN ALL ENCLOSED PUBLIC SPACES AND INCLUDES PROVISIONS FOR TAX RISES, TAPS BANS AND RESTRICTIONS. THIS MARKED THE END OF AN EVENTFUL YEAR IN LATIN AMERICA WHERE SEVERAL COUNTRIES HAVE DEBATED AND ADOPTED STRONGER POLICIES, MOST NOTABLY IS ARGENTINA, WHO APPROVED A NATIONAL TOBACCO CONTROL LAW IN QUARTER 2. AS IN MEXICO, THE SIZE OF GRAPHIC HEALTH WARNINGS (GHW) IN CHILE IS SET TO INCREASE; AND, IN ECUADOR AND HONDURAS LEGAL AND TECHNICAL ASSISTANCE PROVIDED BY THE UNION SUPPORTED THE PASSAGE OF NATIONAL TOBACCO CONTROL LAWS THERE. IN SOUTH EAST ASIA, SMOKEFREE COMPLIANCE WAS NOTED IN INDIA AND INDONESIA. WITH MORE CITIES DECLARING THEMSELVES AS SMOKEFREE ENVIRONMENTS, MANY HAVE REPORTED A GOOD LEVEL OF PUBLIC SUPPORT AND ADHERENCE TO SMOKEFREE LAWS. THIS HAS BEEN BOLSTERED BY SEVERAL INITIATIVES, MOST NOTABLY THE CREATION OF A MAYORS' ALLIANCE IN INDONESIA IN EARLY 2011, DEMONSTRATING POLITICAL COMMITMENT AT A SUB-NATIONAL LEVEL, WHICH WILL SUPPORT THE SUSTAINABILITY OF TOBACCO CONTROL EFFORTS NATIONALLY, IN ADDITION TO INFLUENCE THEY MAY EXERT ON A REGIONAL SCALE. IN A PROMISING MEASURE, BALI PROVINCE COMMITTED TO 100% SMOKE FREE ENVIRONMENTS IN NOVEMBER, WHICH WILL COME INTO FORCE IN MID-2012. NEPAL PASSED THE TOBACCO CONTROL ACT IN QUARTER 2 AND HAS SINCE BEEN ACTIVE ON IMPLEMENTATION, PARTICULARLY ON GHWS ON TOBACCO PRODUCTS.PAKISTAN HAS ALSO MADE ADDITIONAL COMMITMENT TO THE SUSTAINABILITY OF ITS TOBACCO CONTROL PROGRAMME IN LIGHT OF THE DEVOLUTION OF THE MINISTRY OF HEALTH THERE BY REHIRING SOME STAFF. THEY HAVE ALSO BANNED THE SALE OF TOBACCO TO MINORS AND THE SALE OF KIDDIE CIGARETTE PACKETS. DESPITE POLITICAL UNCERTAINTY IN EGYPT, THE UNION IS BUILDING ON MOMENTUM GAINED IN SMOKE FREE CITIES, TAXATION AND GHWS. LEBANON WAS ANOTHER MAJOR SUCCESS STORY THIS YEAR, WITH THE LEBANESE TOBACCO CONTROL LAW BEING ENDORSED IN PARLIAMENT.2011 PROVED TO BE A CHALLENGING YEAR FROM ITS OUTSET, WITH MORE TOBACCO INDUSTRY INTERFERENCE COMING TO THE FORE. IN INDONESIA, SEVERAL CASES WERE FILED TO OVERTURN ELEMENTS OF THE LAW THERE, PARTICULARLY IN RELATION TO GHWS AND THE ADDICTIVE NATURE OF TOBACCO. IN BOGOR CITY, A CIGARETTE COMPANY SOUGHT TO REVOKE THE 100% SMOKE FREE LAW THERE, FOR WHICH THE UNION AND GRANTEES PROVIDED SUPPORT AND TESTIMONY IN DEFENSE OF THE LAW. ON A MORE POSITIVE NOTE, THE TOBACCO CONTROL CELL IN PAKISTAN RAISED THE ISSUES OF TAPS VIOLATIONS LAWS BY PHILLIP MORRIS, WITH TWO OF THE SEVEN CASES REGISTERED AGAINST THE COMPANY PROCEEDING TO COURT.GRANTS - FOLLOWING THE ROUND 10 GRANTS REVIEW MEETING AT THE END OF 2011, SEVEN GRANTS ARE PROCEEDING TO NEGOTIATION, WITH THE UNION COMMITTED TO MANAGING FOUR (COLOMBIA, UGANDA, UKRAINE AND VIETNAM), COVERING AN ARRAY OF TOBACCO CONTROL ISSUES. THE NUMBER OF UNION MANAGED GRANTS ACTIVE AT THE BEGINNING OF 2012 IS 72, WHILE 17 GRANTS ENDED IN QUARTER 4.CAPACITY BUILDING - THE UNION'S TRAINING AND CAPACITY BUILDING FOCUS IN 2011 WAS ON REFINING COURSES TOWARDS A NEEDS-BASED APPROACH, ADAPTING AND DEVELOPING IN RESPONSE TO CHANGES IN TOBACCO CONTROL.ANNUAL REPORT 2011 PAGE 2THE UNION HAS LEANT MORE FLEXIBILITY TO EXISTING COURSES; SYSTEMATIZED TRAINING PRACTICES AND PROCEDURES; AND, ENFORCED THE IMPLEMENTATION OF POST-TRAINING NEEDS ASSESSMENT AND FOLLOW-UP. SIXTEEN MPOWER COURSES WERE HELD (RAISE, PROTECT, ENFORCE AND WARN AND TOBACCO FREE HEALTHCARE FACILITIES) DURING THE YEAR, WITH EACH COUNTRY OR REGION ADAPTING THE COURSE TO ITS PARTICULAR CONTEXT.RESOURCES - RESOURCES PRODUCED THIS YEAR HAVE INCLUDED A BROCHURE FOR EACH OF THE SIX ELEMENTS OF MPOWER, TWO DEPARTMENTAL BROCHURES AND THE RELEASE OF THE BUILDING CAPACITY FOR TOBACCO CONTROL TRAINING PACKAGE.2012 BEGINS WITH RENEWED VIGOR TO TACKLE THE ISSUES THAT MOST CHALLENGE THE COUNTRIES WHERE WE WORK. RAISING PUBLIC AWARENESS OF THE HARMS OF TOBACCO USE AND SECOND-HAND SMOKE REMAINS AN ISSUE IN A NUMBER OF COUNTRIES, INCLUDING CHINA, WHERE THEY AIM TO DEVELOP A MASS MEDIA CAMPAIGN IN COOPERATION WITH BI AND LOCAL PARTNERS TO ADDRESS THIS GROWING CONCERN. INCORPORATING TOBACCO CONTROL INTO MEDICAL CURRICULA IN CHINESE UNIVERSITIES IS ANOTHER CRUCIAL STEP TOWARDS AN INTEGRATED NATIONAL HEALTH STRATEGY. IN ADDITION TO CONTINUING SUPPORT FOR GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS ON TOBACCO CONTROL, THE UNION AND ITS PARTNERS REMAIN AWARE OF CHANGING POLITICAL CONTEXTS, PARTICULARLY IN INDIA, RUSSIA AND THE MIDDLE EAST AT LARGE, ALL WITH ELECTIONS LOOMING, IN ORDER TO ENSURE THAT THE SIGNIFICANT MILESTONES ACHIEVED IN THOSE COUNTRIES ARE NOT DERAILED.</Description>
      </Activity2>
      <Activity3>
        <Expense>2200570</Expense>
        <Grants>2200570</Grants>
        <Description>STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH:THE CENTRE COMMENCED OPERATIONS ON JANUARY 1ST, 2009, AND COMPLETED THE FIRST 2 YEARS IN DEC. 2010. THE FUNDS FOR THE NEXT 2 YEARS (2011-2012) ARRIVED IN AUGUST 2011, AND THIS 7-MONTH DELAY PREVENTED SOME ACTIVITIES ON NON-COMMUNICABLE DISEASES AND VILLAGE REGISTERS BEING INITIATED ON TIME. THIS IS THE ANNUAL REPORT FOR 2011 FOR THE CENTRE FOR STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH. THIS INTRODUCTION IS FOLLOWED BY A SHORT EXECUTIVE SUMMARY WHICH HIGHLIGHTS 12-MONTH ACHIEVEMENTS AGAINST PLANNED TARGETS (ATTAINMENT OF WHICH ARE EXPECTED IN JUNE 2012). THIS IS FOLLOWED BY A NARRATIVE REPORT OF ACTIVITIES AND ACHIEVEMENTS OF THE 12-MONTH PERIOD FROM JAN. TO DEC. 31ST, 2011, AND</Description>
      </Activity3>
      <ActivityOther>
        <Expense>343092</Expense>
        <Description>PUBLIC OPINION FOR ACTION AGAINST LUNG HEALTH PROBLEMS:THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. (IUATLD) RAISES PUBLIC AWARENESS OF AND SUPPORTIVE PUBLIC OPINION FOR INCREASED DOMESTIC AND FOREIGN ASSISTANCE TO COMBAT LUNG HEALTH CHALLENGES AMONG THE POOR IN LOW AND MIDDLE INCOME COUNTRIES FROM THE UNITED STATES GOVERNMENT, PRIVATE CHARITIES, FOUNDATIONS AND OTHER DONORS.EDUCATION AND TRAINING:IUATLD, INC. ORGANIZES AND/OR SUPPORTS IMPORTANT INTERNATIONAL CONFERENCES AND TRAINING PROGRAMS CONFERENCES AND TRAININGS ON TUBERCULOSIS, TOBACCO CONTROL, ASTHMA AND LUNG HEALTH AND WORKS TO INCREASE THE PARTICIPATION OF DOCTORS, NURSES, AND ALLIED HEALTH PERSONNEL FROM LOW AND MIDDLE INCOME COUNTRIES THROUGH THE PROVISION OF TECHNICAL SUPPORT, SCHOLARSHIPS AND TRAVEL GRANTS.PROJECT MANAGEMENT:IUATLD, INC. DIRECTLY MANAGES AND COORDINATES CAPACITY BUILDING, TECHNICAL ASSISTANCE AND RESEARCH PROJECTS FUNDED BY GOVERNMENTAL AND NON-GOVERNMENTAL DONORS IN COLLABORATION WITH MINISTRIES OF HEALTH AND NON-GOVERNMENTAL PARTNERS IN LOW AND MIDDLE INCOME COUNTRIES. THE UNION CONSIDERS ALL POTENTIAL PROJECTS AND DONATIONS IN THE CONTEXT OF OUR GUIDING VALUES: QUALITY (CAN WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST ATTAINABLE STANDARDS?); ACCOUNTABILITY (CAN WE DEMONSTRATE RESPONSIBLE STEWARDSHIP OF RESOURCES AND DELIVER AND REPORT ON OUR COMMITMENTS?); INDEPENDENCE (DO WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION AND SEEK EVIDENCE TO IMPROVE HEALTH AND MANAGEMENT SYSTEMS?); AND SOLIDARITY (CAN WE STAND TOGETHER TO OVERCOME GREAT CHALLENGES AND ACHIEVE BETTER HEALTH AMONG THE COMMUNITIES WE SERVE AND IN PARTICULAR FOR THE POOR?)</Description>
      </ActivityOther>
      <TotalOfOtherProgramServiceExp>343092</TotalOfOtherProgramServiceExp>
      <TotalProgramServiceExpense>23877230</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <SubjectToProxyTax>0</SubjectToProxyTax>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">1</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">0</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc1040000001">1</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc1040000001">0</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc1040000001">0</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc1040000001">1</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc1040000001">1</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities referenceDocumentId="RetDoc1040500001">1</ForeignActivities>
      <MoreThan5000KToOrganizations referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc1041900001">0</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc1042400001">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction>0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>0</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity referenceDocumentId="RetDoc1043400001">0</DisregardedEntity>
      <RelatedEntity referenceDocumentId="RetDoc1043400001">1</RelatedEntity>
      <RelatedOrgControlledEntity>1</RelatedOrgControlledEntity>
      <TransactionRelatedEntity referenceDocumentId="RetDoc1043400001">0</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg referenceDocumentId="RetDoc1043400001">0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>16</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>8</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>1</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>7</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>5</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>1</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>0</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>IL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NJ</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NY</StatesWhereCopyOfReturnIsFiled>
      <OwnWebsite>X</OwnWebsite>
      <OtherWebsite>X</OtherWebsite>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NamePerson>BLERTA SHEHU OPERATIONS MANAGER</NamePerson>
        <TelephoneNumber>2125005738</TelephoneNumber>
        <AddressUS>
          <AddressLine1>61 BROADWAY SUITE 1720</AddressLine1>
          <City>NEW YORK</City>
          <State>NY</State>
          <ZIPCode>10006</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <InfoInScheduleOPartVII>X</InfoInScheduleOPartVII>
      <Form990PartVIISectionA>
        <NamePerson>JOSE LUIS CASTRO</NamePerson>
        <Title>EXECUTIVE DIRECTOR</Title>
        <AverageHoursPerWeek>10.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>100000</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>PETER BALDINI</NamePerson>
        <Title>MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>215000</ReportableCompFromRelatedOrgs>
        <OtherCompensation>30380</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MARIO PIERRO</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>NILS BILLO</NamePerson>
        <Title>MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DEAN SCHRAUFNAGEL</NamePerson>
        <Title>MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MASAE KAWAMURA</NamePerson>
        <Title>MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>SCOTT HALSTEAD</NamePerson>
        <Title>TREASURER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>PAULA FUJIWARA</NamePerson>
        <Title>SENIOR ADVISOR</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <KeyEmployee>X</KeyEmployee>
        <ReportableCompFromOrganization>250000</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>23993</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>250000</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>315000</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>54373</TotalOtherCompensation>
      <NumberIndividualsGT100K>1</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <ContractorCompensation>
        <NameOfContractor>
          <NamePerson>SYLVIANE RATTE</NamePerson>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressForeign>
            <AddressLine1>4 RUE LE BRUN</AddressLine1>
            <City>PARIS</City>
            <Country>FR</Country>
            <PostalCode>75013</PostalCode>
          </AddressForeign>
        </AddressOfContractor>
        <DescriptionOfServices>INTL TOBACCO CONTROL CONSULTING SVCS</DescriptionOfServices>
        <Compensation>137728</Compensation>
      </ContractorCompensation>
      <NumberOfContractorsGT100K>1</NumberOfContractorsGT100K>
      <RelatedOrganizations>18739184</RelatedOrganizations>
      <AllOtherContributions>6186216</AllOtherContributions>
      <TotalContributions>24925400</TotalContributions>
      <InvestmentIncome>
        <TotalRevenueColumn>1246</TotalRevenueColumn>
        <ExclusionAmount>1246</ExclusionAmount>
      </InvestmentIncome>
      <TotalRevenue>
        <TotalRevenueColumn>24926646</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>1246</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>54050</Total>
        <ProgramServices>54050</ProgramServices>
      </GrantsToDomesticOrgs>
      <ForeignGrants>
        <Total>22559564</Total>
        <ProgramServices>22559564</ProgramServices>
      </ForeignGrants>
      <CompCurrentOfficersDirectors>
        <Total>273993</Total>
        <ProgramServices>252236</ProgramServices>
        <ManagementAndGeneral>21757</ManagementAndGeneral>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>375036</Total>
        <ProgramServices>345251</ProgramServices>
        <ManagementAndGeneral>29785</ManagementAndGeneral>
      </OtherSalariesAndWages>
      <PensionPlanContributions>
        <Total>6791</Total>
        <ProgramServices>5972</ProgramServices>
        <ManagementAndGeneral>819</ManagementAndGeneral>
      </PensionPlanContributions>
      <OtherEmployeeBenefits>
        <Total>63428</Total>
        <ProgramServices>60270</ProgramServices>
        <ManagementAndGeneral>3158</ManagementAndGeneral>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>46253</Total>
        <ProgramServices>41482</ProgramServices>
        <ManagementAndGeneral>4771</ManagementAndGeneral>
      </PayrollTaxes>
      <FeesForServicesLegal>
        <Total>9889</Total>
        <ProgramServices>9799</ProgramServices>
        <ManagementAndGeneral>90</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>21900</Total>
        <ProgramServices>20000</ProgramServices>
        <ManagementAndGeneral>1900</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <FeesForServicesOther>
        <Total>147000</Total>
        <ProgramServices>143419</ProgramServices>
        <ManagementAndGeneral>3581</ManagementAndGeneral>
      </FeesForServicesOther>
      <OfficeExpenses>
        <Total>97115</Total>
        <ProgramServices>83670</ProgramServices>
        <ManagementAndGeneral>13445</ManagementAndGeneral>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>60010</Total>
        <ProgramServices>59850</ProgramServices>
        <ManagementAndGeneral>160</ManagementAndGeneral>
      </InformationTechnology>
      <Occupancy>
        <Total>176344</Total>
        <ProgramServices>124635</ProgramServices>
        <ManagementAndGeneral>51709</ManagementAndGeneral>
      </Occupancy>
      <Travel>
        <Total>61560</Total>
        <ProgramServices>59978</ProgramServices>
        <ManagementAndGeneral>1582</ManagementAndGeneral>
      </Travel>
      <ConferencesMeetings>
        <Total>33068</Total>
        <ProgramServices>33032</ProgramServices>
        <ManagementAndGeneral>36</ManagementAndGeneral>
      </ConferencesMeetings>
      <DepreciationDepletion>
        <Total>1990</Total>
        <ProgramServices>1990</ProgramServices>
      </DepreciationDepletion>
      <Insurance>
        <Total>21374</Total>
        <ProgramServices>11555</ProgramServices>
        <ManagementAndGeneral>9819</ManagementAndGeneral>
      </Insurance>
      <OtherExpenses>
        <Description>EQUIP RENTAL &amp; REPAIR</Description>
        <Total>4698</Total>
        <ProgramServices>4210</ProgramServices>
        <ManagementAndGeneral>488</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>STAFF DEVLPMT &amp; RECRUIT</Description>
        <Total>3959</Total>
        <ProgramServices>3654</ProgramServices>
        <ManagementAndGeneral>305</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>OTHER EXPENSES</Description>
        <Total>2908</Total>
        <ProgramServices>2613</ProgramServices>
        <ManagementAndGeneral>295</ManagementAndGeneral>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>24020930</Total>
        <ProgramServices>23877230</ProgramServices>
        <ManagementAndGeneral>143700</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>75441</BOY>
        <EOY>1786624</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>462446</BOY>
        <EOY>60171</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>1516523</BOY>
        <EOY>6908116</EOY>
      </PledgesAndGrantsReceivable>
      <PrepaidExpensesDeferredCharges>
        <BOY>11470</BOY>
        <EOY>0</EOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>5970</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>3728</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>1467</BOY>
        <EOY>2242</EOY>
      </LandBuildingsEquipmentBasisNet>
      <OtherAssetsTotal>
        <BOY>429350</BOY>
        <EOY>807493</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>2496697</BOY>
        <EOY>9564646</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>43630</BOY>
        <EOY>76135</EOY>
      </AccountsPayableAccruedExpenses>
      <GrantsPayable>
        <BOY>2451623</BOY>
        <EOY>7278086</EOY>
      </GrantsPayable>
      <EscrowAccountLiability>
        <BOY>74931</BOY>
        <EOY>1378196</EOY>
      </EscrowAccountLiability>
      <TotalLiabilities>
        <BOY>2570184</BOY>
        <EOY>8732417</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>-73487</BOY>
        <EOY>32799</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <EOY>799430</EOY>
      </TemporarilyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>-73487</BOY>
        <EOY>832229</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>2496697</BOY>
        <EOY>9564646</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>905716</ReconcilationRevenueExpenses>
      <ReconcilationOtherChanges>0</ReconcilationOtherChanges>
      <InfoInScheduleOPartXII>X</InfoInScheduleOPartXII>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>1</AuditCommittee>
      <FinancialStatementBoth>X</FinancialStatementBoth>
      <FederalGrantAuditRequired>1</FederalGrantAuditRequired>
      <FederalGrantAuditPerformed>1</FederalGrantAuditPerformed>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>16049</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5279</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>19419094</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>20284523</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>24925400</CurrentTaxYear>
        <Total>64650345</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>16049</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5279</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>19419094</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>20284523</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>24925400</CurrentTaxYear>
        <Total>64650345</Total>
      </Total170>
      <AmountsSubstContributorsTotal>6276009</AmountsSubstContributorsTotal>
      <PublicSupportTotal170>58374336</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>231</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>88</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>11877</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>12005</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>1246</CurrentTaxYear>
        <Total>25447</Total>
      </GrossInvestmentIncome170>
      <OtherIncome170>
        <CurrentTaxYearMinus1Year>221</CurrentTaxYearMinus1Year>
        <Total>221</Total>
      </OtherIncome170>
      <TotalSupport>64676013</TotalSupport>
      <PublicSupportPertcentage170>0.90260</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.90710</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
      <GeneralExplanation>SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: REBATES &amp; REFUNDS FOR INSURANCE PREMIUMS = $221.00</GeneralExplanation>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <AgentTrusteeEtc>0</AgentTrusteeEtc>
      <IncludedOnFS>1</IncludedOnFS>
      <Equipment>
        <OtherCostOrOtherBasis>5970</OtherCostOrOtherBasis>
        <Depreciation>3728</Depreciation>
        <BookValue>2242</BookValue>
      </Equipment>
      <TotalOfBookValueLandBuildings>2242</TotalOfBookValueLandBuildings>
      <OtherAssets>
        <Description>DUE FROM AFFILIATE - IUATLD, INC. (PARIS)</Description>
        <BookValue>807493</BookValue>
      </OtherAssets>
      <TotalBookValueOtherAssets>807493</TotalBookValueOtherAssets>
      <TotalRevenue>24926646</TotalRevenue>
      <TotalExpenses>24020930</TotalExpenses>
      <ExcessOrDeficitForYear>905716</ExcessOrDeficitForYear>
      <ExcessOrDeficitPerFS>905716</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>24926646</TotRevenueEtcAuditedFinclStmt>
      <RevenueNotRptdF990>0</RevenueNotRptdF990>
      <RevenueSubtotal>24926646</RevenueSubtotal>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>24926646</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>24020930</TotExpensesEtcAuditedFinclStmt>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>24020930</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>24020930</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <ReturnReference>PART IV, LINE 2B:</ReturnReference>
        <Explanation>THE INTERNATIONAL UNION AGAINST TUBERCULOSIS &amp; LUNG DISEASE (IUATLD) IS ACTING AS FIDUCIARY FISCAL AGENT FOR THE NORTH AMERICAN REGION (NAR) CONFERENCE. THESE FUNDS ARE USED FOR NAR-RELATED EXPENSES AND ARE FURNISHED UPON REQUEST TO THE BRITISH COLUMBIA LUNG ASSOCIATION. THESE FUNDS REPRESENTED THE BALANCE OF ALL NAR NET PROCEEDS THROUGH JANUARY 31, 2011. THESE AMOUNTS WERE PREVIOUSLY MAINTAINED BY THE AMERICAN LUNG ASSOCIATION OF THE UPPER MIDWEST AS THE SECRETARIAT. THE SECRETARIAT ROLE INCLUDED DUTIES AS SECRETARY OF THE ANNUAL CONFERENCE AND FIDUCIARY FISCAL AGENT FOR THE CONFERENCE. THE SECRETARIAT RELATIONSHIP HAS ENDED AND THE FUND BALANCE WAS REMITTED TO THE IUATLD. ALL ADDITIONAL FUNDS DIRECTED TO THE AMERICAN LUNG ASSOCIATION ARE TRANSFERRED TO THE IUATLD WHEN RECEIVED.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:</Identifier>
        <ReturnReference>PART X:</ReturnReference>
        <Explanation>IUATLD, INC. RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE IUATLD, INC. HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION. IUATLD, INC. IS NO LONGER SUBJECT TO AUDITS BY THE APPLICABLE TAXING JURISDICTIONS FOR PERIODS PRIOR TO 2008.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintained>1</GrantRecordsMaintained>
      <AcctsActvsOutUSTable>
        <Region>EUROPE</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS TO RECIPIENTS LOCATED IN THE REGION</TypeOfActivitiesConducted>
        <SpecificServicesProvided>GRANTS TO RECIPIENTS IN THE REGION</SpecificServicesProvided>
        <TotalExpenditures>13494787</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>ASIA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS TO RECIPIENTS LOCATED IN THE REGION</TypeOfActivitiesConducted>
        <SpecificServicesProvided>GRANTS TO RECIPIENTS IN THE REGION; MANAGEMENT TRAINING</SpecificServicesProvided>
        <TotalExpenditures>4218041</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>AFRICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS TO RECIPIENTS LOCATED IN THE REGION</TypeOfActivitiesConducted>
        <SpecificServicesProvided>GRANTS TO RECIPIENTS IN THE REGION</SpecificServicesProvided>
        <TotalExpenditures>2105772</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>NORTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS TO RECIPIENTS LOCATED IN THE REGION</TypeOfActivitiesConducted>
        <SpecificServicesProvided>GRANTS TO RECIPIENTS IN THE REGION</SpecificServicesProvided>
        <TotalExpenditures>379813</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>SOUTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS TO RECIPIENTS LOCATED IN THE REGION</TypeOfActivitiesConducted>
        <SpecificServicesProvided>GRANTS TO RECIPIENTS IN THE REGION</SpecificServicesProvided>
        <TotalExpenditures>2361151</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <SubtotalNumberOfOffices>0</SubtotalNumberOfOffices>
      <SubtotalNumberOfEmployees>0</SubtotalNumberOfEmployees>
      <ContNumberOfOffices>0</ContNumberOfOffices>
      <ContNumberOfEmployees>0</ContNumberOfEmployees>
      <TotalNumberOfOffices>0</TotalNumberOfOffices>
      <TotalNumberOfEmployees>0</TotalNumberOfEmployees>
      <SubtotalAmountSpent>22559564</SubtotalAmountSpent>
      <ContAmountSpent>0</ContAmountSpent>
      <TotalAmountSpent>22559564</TotalAmountSpent>
      <NoRecipientOver5K>X</NoRecipientOver5K>
      <GrantsToOrgsOutsideUS>
        <Region>EUROPE</Region>
        <PurposeOfGrant>BLOOMBERG INITIATIVE TO REDUCE TOBACCO USE</PurposeOfGrant>
        <AmountOfCashGrant>13494787</AmountOfCashGrant>
        <MannerOfCashDisbursement>WIRE TRANSFER</MannerOfCashDisbursement>
        <DescriptionOfNonCashAssistance>N/A</DescriptionOfNonCashAssistance>
        <MethodOfValuation>N/A</MethodOfValuation>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>ASIA</Region>
        <PurposeOfGrant>TO CONDUCT INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM COSTS</PurposeOfGrant>
        <AmountOfCashGrant>4218041</AmountOfCashGrant>
        <MannerOfCashDisbursement>WIRE TRANSFER</MannerOfCashDisbursement>
        <DescriptionOfNonCashAssistance>N/A</DescriptionOfNonCashAssistance>
        <MethodOfValuation>N/A</MethodOfValuation>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>AFRICA</Region>
        <PurposeOfGrant>TO REDUCE TOBACCO USE AND CONDUCT STRATEGIC HEALTH INFO.AND OPERATIONAL RESEARCH</PurposeOfGrant>
        <AmountOfCashGrant>2105772</AmountOfCashGrant>
        <MannerOfCashDisbursement>WIRE TRANSFER</MannerOfCashDisbursement>
        <MethodOfValuation>N/A</MethodOfValuation>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>NORTH AMERICA</Region>
        <PurposeOfGrant>TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS</PurposeOfGrant>
        <AmountOfCashGrant>379813</AmountOfCashGrant>
        <MannerOfCashDisbursement>WIRE TRANSFER</MannerOfCashDisbursement>
        <MethodOfValuation>N/A</MethodOfValuation>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>SOUTH AMERICA</Region>
        <PurposeOfGrant>TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS</PurposeOfGrant>
        <AmountOfCashGrant>2361151</AmountOfCashGrant>
        <MannerOfCashDisbursement>WIRE TRANSFER</MannerOfCashDisbursement>
        <MethodOfValuation>N/A</MethodOfValuation>
      </GrantsToOrgsOutsideUS>
      <TotalNumberOf501c3Orgs>0</TotalNumberOf501c3Orgs>
      <TotalNumberOfOtherOrgs>47</TotalNumberOfOtherOrgs>
      <TransferToForeignCorp>0</TransferToForeignCorp>
      <InterestInForeignTrust>0</InterestInForeignTrust>
      <OwnForeignCorp>0</OwnForeignCorp>
      <PassiveForeignInvestCo>0</PassiveForeignInvestCo>
      <ForeignPartnership>0</ForeignPartnership>
      <BoycottCountries>0</BoycottCountries>
      <Form990ScheduleFPartV>
        <Identifier>PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:</Identifier>
        <Explanation>SCHEDULE F, PART I, LINE 2: IUATLD, INC. IS BOTH A RECIPIENT AND ISSUER OF GRANT FUNDING. THE ORGANIZATION MAINTAINS A GRANT FUNDING MONITORING SYSTEM TO EFFECTIVELY MONITOR AND REPORT RESULTS OF GRANT FUNDING ISSUED TO RECIPIENTS. THIS SYSTEM FEATURES A STANDARDIZED GRANTS FUNDING AGREEMENT AND REPORTING FORMAT. VARIOUS IUATLD, INC. STAFF ARE INVOLVED IN THE SYSTEM ESTABLISHED TO ISSUE AND MONITOR GRANT FUNDS. THIS INCLUDES THE FINANCE AND OPERATIONS OFFICER, WHO OVERSEES THE PROCESS TO ISSUE GRANT FUNDING AGREEMENTS, AND THE RESEARCH AND EVALUATION COORDINATOR WHO OVERSEES DAY TO DAY MANAGEMENT OF INFORMATION RELATED TO RECIPIENT PROGRESS AND REPORTS.</Explanation>
      </Form990ScheduleFPartV>
      <Form990ScheduleFPartV>
        <Identifier>METHOD USED TO ACCCOUNT FOR EXPENDITURES:</Identifier>
        <Explanation>SCHEDULE F, PART I, LINE 3: EXPENDITURES ARE RECOGNIZED UNDER THE ACCRUAL BASIS OF ACCOUNTING.</Explanation>
      </Form990ScheduleFPartV>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <RecordsMaintained>0</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>BRIGHAM &amp; WOMEN'S HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>75 FRANCIS STREET</AddressLine1>
          <City>BOSTON</City>
          <State>MA</State>
          <ZIPCode>02115</ZIPCode>
        </AddressUS>
        <EINOfRecipient>042312909</EINOfRecipient>
        <IRCSection>501(C)(3)</IRCSection>
        <AmountOfCashGrant>31665</AmountOfCashGrant>
        <PurposeOfGrant>TREAT TB PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>ENCOMPASS LLC</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>11461 ROCKVILLE PIKE SUITE 229</AddressLine1>
          <City>ROCKVILLE</City>
          <State>MD</State>
          <ZIPCode>20582</ZIPCode>
        </AddressUS>
        <EINOfRecipient>522228651</EINOfRecipient>
        <IRCSection>N/A</IRCSection>
        <AmountOfCashGrant>22385</AmountOfCashGrant>
        <PurposeOfGrant>TREAT TB PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <PurposeOfGrant>TOBACCO CONTROL RUSSIA</PurposeOfGrant>
      </RecipientTable>
      <TotalNbrOf501C3AndGovtGrants>2</TotalNbrOf501C3AndGovtGrants>
      <Form990ScheduleIPartIV>
        <Identifier>SCHEDULE I, PART I, LINE 2</Identifier>
        <Explanation>THE SUB-GRANTESS ARE REQUIRED TO SUBMIT QUARTERLY FINANCIAL REPORTS AND NARRATIVES TO PROJECT MANAGERS. VARIANCES FROM THE APPROVED BUDGET ARE SCRUTINIZED AND EXPLAINED. ORGANIZATION ALSO REQUEST THE ANNUAL FINANCIAL STATEMENT AND AUDITOR'S REPORT FROM SUB-GRANTEES. PROJECT MANAGER CONDUCTS INTERNAL AUDIT ON-SITE WHEN NEEDED.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <IndependentConsultant>X</IndependentConsultant>
      <Form990OfOtherOrganizations>X</Form990OfOtherOrganizations>
      <WrittenEmploymentContract>X</WrittenEmploymentContract>
      <CompensationSurvey>X</CompensationSurvey>
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>PETER BALDINI</NamePerson>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>195000</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>20000</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>7800</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>22580</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>245380</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NamePerson>PAULA FUJIWARA</NamePerson>
        <BaseCompensationFilingOrg>250000</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>10000</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>13993</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>273993</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <Identifier>ORGANIZATION MISSION STATEMENT</Identifier>
        <ReturnReference>FORM 990, PART I, LINE 1</ReturnReference>
        <Explanation>B. SUBMISSION OF THE SYSTEMATIC REVIEW ON IGRAS IN CHILDREN FOR PUBLICATION IN THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE IN OCTOBER 2010. TREAT TB ALSO PROVIDED THE RESULTS OF THIS STUDY TO THE WHO EXPERT GROUP MEETING ON IGRAS IN JULY 2010 AND THE WHO STRATEGIC AND TECHNICAL ADVISORY GROUP FOR TB IN SEPTEMBER 2010. C. DEVELOPMENT AND IMPLEMENTATION OF THE SOUTH AFRICA PROVE IT PROTOCOL. THE TREAT TB CORE TEAM WORKED CLOSELY WITH PARTNERS FROM THE DESMOND TUTU TB CENTRE (DTTC) TO DEVELOP AND FINALIZE THEIR COUNTRY PROTOCOL. AFTER RECEIVING EAG APPROVAL IN LATE 2010, TREAT TB'S LOCAL PARTNER, THE DESMOND TUTU TB CENTRE, BEGAN TO IMPLEMENT THE STUDY IN EARLY 2011. D. DESIGN OF THE NATIONAL PROVE IT STUDY AND PREPARATION FOR IMPLEMENTATION IN BRAZIL. IN 2010, THE TREAT TB COORDINATION TEAM ESTABLISHED PARTNERSHIPS WITH THE KEY PLAYERS IN BRAZIL AND WORKED COLLABORATIVELY WITH THEM TO DESIGN THE STUDY PROTOCOL FOR THIS SETTING. TO PREPARE FOR THE IMPLEMENTATION OF THE PROVE IT STUDY IN BRAZIL, REDE TB STAFF HELD SEVERAL TRAINING EVENTS FOR STUDY PERSONNEL AND MEMBERS OF THE COMMUNITY ADVISORY BOARDS (CAB) IN THE THREE STUDY SITES IN ADDITION TO MULTIPLE PROVE IT MEETINGS AT REDE TB HEADQUARTERS IN RIO DE JANEIRO. E. ADAPTATION OF THE GENERIC PROTOCOL TO THE RUSSIAN CONTEXT. IN PARTNERSHIP WITH THE NORTHERN STATE MEDICAL UNIVERSITY, THE TREAT TB COORDINATION TEAM TAILORED TO THE GENERIC PROTOCOL TO ALIGN WITH THE NEEDS OF THE TB COMMUNITY IN ARKHANGELSK, RUSSIA. THE PROVE IT STUDY IN THE ARKHANGELSK REGION WILL EVALUATE THE IMPACT OF LPA ON CIVILIAN PATIENTS AS WELL AS THOSE INCARCERATED IN THE PENITENTIARY SYSTEM. F. LOCAL AND UNION ETHICS APPROVAL FOR PROVE IT STUDIES. IN ADDITION TO OBTAINING THE APPROVAL OF LOCAL ETHICS COMMITTEES IN BRAZIL, RUSSIA, AND SOUTH AFRICA, TREAT TB OBTAINED THE APPROVAL FROM THE UNION'S ETHICS ADVISORY GROUP (EAG) FOR THE SOUTH AFRICA AND RUSSIA STUDIES. THE EAG IS CURRENTLY REVIEWING THE APPLICATION AND SUPPORTING DOCUMENTS FOR THE STUDY IN BRAZIL. G. SUBMISSION OF TREAT TB SYSTEMATIC REVIEWS TO PEER-REVIEWED PUBLICATIONS. THROUGHOUT FALL 2010, TREAT TB PARTNER, MCGILL UNIVERSITY SUBMITTED THREE REVIEWS FOR PUBLICATION. THE USE OF MODS OR THIN LAYER AGAR (TLA) TECHNIQUES FOR THE DIAGNOSIS OF ACTIVE TUBERCULOSIS AND/OR DRUG SENSITIVITY TESTING: SYSTEMATIC REVIEW AND META-ANALYSIS AND THE URINARY LIPOARABINOMANNAN (LAM) ANTIGEN DETECTION FOR THE DIAGNOSIS OF TUBERCULOSIS: SYSTEMATIC REVIEW AND META-ANALYSIS ARE CURRENTLY BEING REVIEWED BY WIDELY READ PUBLIC HEALTH JOURNALS. THE INTERFERON-GAMMA RELEASE ASSAYS (IGRAS) FOR THE DETECTION OF MYCOBACTERIUM TUBERCULOSIS INFECTION IN CHILDREN REVIEW WAS ACCEPTED BY THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE IN LATE 2010 AND IS EXPECTED TO BE PUBLISHED IN NOVEMBER 2011. TECHNICAL PROJECT ACTIVITY 2: DEVELOPING MODELING METHODS FOR COUNTRY GUIDANCE KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. CREATION THE PROTOTYPE MODEL FOCUSED ON DIAGNOSTICS FOR DRUG-SENSITIVE TB. THROUGH SEVERAL PRODUCTIVE CALLS AND IN-PERSON MEETINGS, THE TEAM WAS ABLE TO DEVELOP A TWO-PRONGED MODELING APPROACH THAT UTILIZES TRANSMISSION AND OPERATIONAL MODELING. B. FINALIZATION OF THE TREAT TB MODELLING APPROACH FOR DRUG-SENSITIVE TB. TECHNICAL PROJECT ACTIVITY 3: FOSTERING COUNTRY RESEARCH TO OPTIMIZE PROGRAM PERFORMANCE KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. TREAT TB'S LOCAL PARTNER, THE DESMOND TUTU TB CENTRE (DTTC), CONDUCTED THE DRUG RESISTANCE IN CHILDREN STUDY. THE STUDY AIMS TO EVALUATE THE ACCESS TO CARE AMONG CHILDREN AT-RISK OF DEVELOPING DRUG-RESISTANT TB IN THE WESTERN CAPE. DTTC RECRUITED 196 CHILDREN INTO THE PREVENTATIVE TREATMENT STUDY AMONG PEDIATRIC MDR CONTACTS AND OF THESE, 112 WERE SEEN FOR FOLLOW-UP AT TWO MONTHS, 72 AT FOUR MONTHS AND 56 AT SIX MONTHS DURING THE REPORTING PERIOD. B. DTTC HAS MOVED AHEAD WITH THE DRUG RESISTANCE IN A COMMUNITY STUDY AND IS EXPECTED TO COMPLETE THE DATA ANALYSIS OF THIS STUDY'S FINDINGS BY MARCH 2011. C. TREAT TB AND DTTC IMPLEMENTED AN OPERATIONAL RESEARCH PROTOCOL DEVELOPMENT WORKSHOP WHICH RESULTED IN THE DEVELOPMENT OF 12 RESEARCH PROTOCOLS FOCUSED ON TOPICS PRIORITIZED WITHIN THE NATIONAL RESEARCH AGENDA OF SOUTH AFRICA. TWENTY-FIVE RESEARCHERS FROM LOCAL ACADEMIC INSTITUTIONS AND HEALTH DEPARTMENTS PARTICIPATED IN THE EVENT, WHICH WAS HELD AT THE LANZERAC HOTEL IN STELLENBOSCH ON MAY 10-15, 2010. D. OF THE 15 PROTOCOLS MENTIONED ABOVE, DTTC FACILITATED THE SUCCESSFUL ETHICS REVIEW OF 12. E. TREAT TB'S LOCAL PARTNERS IN MALAWI ARE COMPLETING THEIR STUDY ON OPPORTUNISTIC INFECTIONS AMONG PEOPLE INITIATING ARV TREATMENT. THE PRELIMINARY RESULTS SHOW THAT 33% OF PATIENTS WERE DIAGNOSED WITH A SERIOUS PATHOGEN ONLY BECAUSE OF THE EXTRA TESTS CONDUCTED BY THE TREAT TB STUDY TEAM. THE RESEARCH TEAM ALSO FOUND THAT 16% OF PATIENTS ENROLLED IN THE STUDY HAVE UNDIAGNOSED TB. F. TREAT TB CONVENED MEETINGS WITH USAID MISSION PERSONNEL IN INDIA AND MOZAMBIQUE TO DISCUSS SUPPORT FOR URGENT RESEARCH PROJECTS IN THESE COUNTRIES. TREAT TB AND ITS REGIONAL PARTNERS IN INDIA AND BRAZIL SUBMITTED PROPOSALS TO THE USAID MISSIONS IN NEW DELHI AND MAPUTO, MOZAMBIQUE RESPECTIVELY WHICH ARE CURRENTLY PENDING USAID REVIEW. TECHNICAL PROJECT ACTIVITY 4: DEVELOPMENT AND IMPLEMENTATION OF RESEARCH STUDIES TO IMPROVE PATIENT MANAGEMENT, TREATMENT EFFICACY AND DISEASE PREVENTION KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE: A. HOLDING A MEETING WITH ALL STUDY PARTNERS IN PARIS, FRANCE TO FINALIZE THE PROTOCOL AND DISCUSS IMPLEMENTATION ISSUES SUCH AS POSSIBLE SALVAGE REGIMENS AND THE PROCUREMENT OF REGIMEN COMPOUNDS. B. OBTAINING THE SUPPORT OF THE GREEN LIGHT COMMITTEE, WHOSE ASSISTANCE WILL ENABLE THE UNION TO PROCURE THE DRUGS FOR THE STUDY IN A TIMELY, COST-EFFECTIVE MANNER. C. MEETING WITH NTP OFFICIALS AND EVALUATED FOUR SITES IN VIETNAM, INCLUDING TWO DIFFERENT TB HOSPITALS IN HANOI, THE PHAM NGOC THACH HOSPITAL IN HO CHI MINH CITY AND A TB OUTPATIENT CLINIC AFFILIATED WITH THE PHAM NGOC HOSPITAL IN THE CENTER OF HO CHI MINH CITY. TREAT TB STAFF ALSO MET WITH THE USAID MISSION IN HANOI. D. CONDUCTING A THOROUGH ASSESSMENT OF SEVERAL POTENTIAL STREAM STUDY SITES IN SOUTH AFRICA. THE STREAM DELEGATION ALSO MET WITH USAID MISSION STAFF AND NTP OFFICIALS. E. IMPLEMENTATION VISIT TO INDIA IN NOVEMBER 2010, AS WELL AS A COMPREHENSIVE ASSESSMENT OF TWO TB HOSPITALS IN ADDIS ABABA, ETHIOPIA TO MEET WITH SENIOR MINISTRY OF HEALTH OFFICIALS. F. ORGANIZED THE FIRST STUDY MEETING WITH MEMBERS OF THE STEERING COMMITTEE ON 15 NOVEMBER 2010, DURING THE WORLD CONFERENCE ON LUNG HEALTH IN BERLIN, GERMANY. THE AIM OF THIS MEETING WAS TO DISCUSS THE IMPLEMENTATION OF THE STUDY AND THE PREPARATION COMPLETED TO DATE. G.CONDUCTED A VISIT TO NEW DELHI TO DISCUSS THE IMPLEMENTATION OF THE STREAM STUDY IN INDIA. THE STREAM RESEARCH TEAM IS IN DISCUSSION WITH NTP OFFICIALS AND POTENTIAL SITES. TECHNICAL PROJECT ACTIVITY 5: PROJECT COORDINATION, REVIEW AND SUPPORT ACTIVITIES KEY RESULTS AND ACCOMPLISHMENTS IN 2010: A. CONTINUED TO INFORM HUNDREDS OF PUBLIC HEALTH SPECIALISTS ABOUT TREAT TB'S WORK THROUGH THE BI-MONTHLY E-NEWSLETTER. B. CONVENED A TREAT TB PARTNERS MEETING IN RIO DE JANEIRO, BRAZIL ON 24-25 MAY 2010, WITH LOGISTICAL SUPPORT PROVIDED BY REGIONAL PARTNER REDE-TB, WHICH ENABLED PARTNERS AND UNION STAFF TO GAUGE PROGRESS AND PLAN THE INITIATIVE'S NEXT STEPS. THE EXPANDED SET OF COLLABORATORS AND PARTNERS WHO PARTICIPATED THIS MEETING INCLUDED MRC AND KNCV. THE LATTER HAS PROVIDED CRUCIAL ASSISTANCE IN THE IMPLEMENTATION OF THE STREAM STUDY IN SEVERAL TARGET COUNTRIES, PARTICULARLY VIETNAM. C. DISSEMINATED INFORMATION AND UPDATES ABOUT THE TREAT TB INITIATIVE ON A VARIETY OF PLATFORMS INCLUDING THE BI-MONTHLY TREAT TB E-NEWSLETTER, THE TREAT TB WEBSITE, THE UNION WEBSITE, AND EXTERNAL PUBLICATIONS RANGING FROM HEALTH-FOCUSED ONLINE MAGAZINES TO THE STOP TB QUARTERLY NEWSLETTER. THROUGH THESE EFFORTS, HUNDREDS OF GLOBAL HEALTH PROFESSIONALS RECEIVED INFORMATION ABOUT TREAT TB ACTIVITIES AND EVENTS. D. PARTICIPATED IN SEVERAL LUNG HEALTH CONFERENCES AND MEETINGS INCLUDING WHO WORKSHOPS, THE INTERNATIONAL CHILDHOOD TUBERCULOSIS MEETING, AND THE UNION'S 15TH ANNUAL NORTH AMERICAN REGION CONFERENCE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Explanation>IS ACCOMPANIED BY I) THE QUARTERLY REPORTING TEMPLATE DETAILING ACHIEVEMENTS AGAINST OBJECTIVES AND ACTIVITIES, AND II) THE BUDGET EXPENDITURES. EXECUTIVE SUMMARY: TARGET: JUL 2011- JUN 2012; ACHIEVEMENT: JAN 2011 - DEC 2011 ACTIVITY: NEW DIABETES AND/OR HYPERTENSIVE PATIENTS MONITORED IN DOTS REGISTRY FRAMEWORK. TARGET: 2,000 BY JULY 2012, ACHIEVEMENT: 516 IN 12 MONTHS BY DEC. 2011* ACTIVITY: NEW HIV/AIDS INCLUDING TB, PATIENTS MONITORED IN DOTS REGISTRY FRAMEWORK, TARGET: 50,000 BY JULY 2012, ACHIEVEMENT: 81,796 IN 12 MONTHS BY DECEMBER 2011 ACTIVITY: NEW DIABETES, HYPERTENSIVE, TB AND HIV PATIENTS MONITORED USING AN ELECTRONIC PLATFORM USING DOTS REGISTRY FRAMEWORK, TARGET: 2,000 BY JULY 2012, ACHIEVEMENT: 56,360 IN 12 MONTHS BY DECEMBER 2011. ACTIVITY: DISTRICT WIDE DEATH REGISTRY IN PLACE WITH DATA BEING TRANSFERRED, TARGET: VILLAGE REGISTERS IN ONE DISTRICT IN PLACE BY JUNE 2012, ACHIEVEMENT: VILLAGE REGISTERS IN PLACE: DATA TRANSFER BEING WORKED ON. ACTIVITY: OPERATIONAL RESEARCH PAPERS PUBLISHED AND AT LEAST ONE NEW FELLOW TRAINED, TARGET: 20 PAPERS AND 1 NEW OR FELLOW TRAINED BY JUNE 2012, ACHIEVEMENT: 69 PUBLISHED PAPERS IN 12 MONTHS BY DEC 2011 AND 1 NEW OR FELLOW TRAINED * 2 NEW DM CLINICS STARTED IN DECEMBER 2011 AND ALREADY RECRUITING PATIENTS NARRATIVE REPORT AGAINST OBJECTIVES: 1.USE OF DOTS FRAMEWORK TO TRACK DIFFERENT DISEASES. THE CENTRE ADAPTED THE TB "DOTS" FRAMEWORK TO HELP TRACK DIFFERENT INFECTIOUS AND NON-INFECTIOUS DISEASES, AND HAS BEEN PIONEERING THIS APPROACH IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY (ART) IN MALAWI AND MYANMAR AND IN PATIENTS WITH DIABETES MELLITUS IN MALAWI. ART IN MALAWI: WITH HIV-INFECTED PATIENTS ON ART, ON-GOING COLLABORATION IS MAINTAINED WITH THE HIV UNIT OF THE MINISTRY OF HEALTH IN MALAWI IN TERMS OF INDIRECT TECHNICAL ASSISTANCE. NATIONAL SUPERVISION AND MONITORING AND EVALUATION AGAINST ALL ODDS (NO FUEL) TOOK PLACE BETWEEN OCT. AND DEC. 2011 TO REPORT ON NATIONAL DATA IN BOTH THE PUBLIC AND PRIVATE SECTOR UP TO THE END OF SEPT. 2011. BY SEPT. 30TH, 2011, A TOTAL OF 408,236 PATIENTS HAD EVER BEEN INITIATED ON ART IN BOTH PUBLIC AND PRIVATE SECTORS AND HAD KNOWN TREATMENT OUTCOMES: OF THESE, 292,372 PATIENTS WERE ALIVE AND ON ART AT THEIR ORIGINAL REGISTRATION CLINIC, AND CAN BE STRATIFIED BY ART REGIMEN. FULL REPORTS ARE AVAILABLE ON REQUEST. HIV CARE IN MYANMAR: LINKS WERE FORMED WITH THE UNION OFFICE IN MYANMAR TO HELP SUPPORT THE REGULAR, TIMELY AND ACCURATE RECORDING AND REPORTING OF DATA IN HIV-INFECTED PATIENTS UNDER CARE AND TREATMENT. DATA WERE COLLECTED IN THE FOURTH QUARTER OF 2011 FOR THE PREVIOUS QUARTER. BY SEPT. 30TH, 2011, THERE WERE 13,004 HIV-INFECTED PATIENTS EVER ENROLLED TO CARE AND 10,004 ON ACTIVE FOLLOW UP. OF THESE, THERE WERE 8,856 STARTED ON ART OF WHOM 7,438 WERE ALIVE AND RETAINED ON TREATMENT. MANAGING DIABETES AND HYPERTENSION IN MALAWI: A DOTS MODEL WAS DEVELOPED DURING THE LAST THREE YEARS FOR NON-COMMUNICABLE DISEASES, AND WORK IS ON-GOING IN MALAWI TO USE THIS MODEL FOR MANAGING DIABETES MELLITUS IN THREE CENTRAL HOSPITALS AND THE SOUTHERN REGION OF THE COUNTRY. BY SEPTEMBER 30TH, 2011, THERE WERE 2,210 DM PATIENTS (884 MALE AND 1326 FEMALE) IN QUEEN ELIZABETH CENTRAL HOSPITAL, BLANTYRE, REGISTERED UNDER THE DOTS MODEL. QUARTERLY COHORT REPORTING HAS BEEN SET UP, AND 2193 OF THESE PATIENTS WERE ALIVE AND IN CARE IN QECH. KAMUZU CENTRAL HOSPITAL, LILONGWE, AND ZOMBA CENTRA HOSPITAL, ZOMBA, BOTH WENT "LIVE" FOR DM CARE BEFORE THE END OF 2012 WITH EACH REGISTERING JUST OVER 40 PATIENTS. ADDITIONAL SUPPORT FOR THIS ACTIVITY HAS BEEN OBTAINED FROM THE WORLD DIABETES FOUNDATION. DISCUSSIONS HAVE ALSO TAKEN PLACE WITH THE NEW MOH DIRECTOR OF NON-COMMUNICABLE DISEASE ABOUT SETTING UP A "CHRONIC DISEASE CARE" CLINIC TO MANAGE DM, HYPERTENSION, CARDIOVASCULAR DISEASE, ASTHMA AND EPILEPSY. BY SEPTEMBER 30TH, 2011, A CUMULATIVE TOTAL OF 423,450 PATIENTS IN MALAWI AND MYANMAR WITH HIV/AIDS, TUBERCULOSIS AND DIABETES HAD EVER BEEN INITIATED ON TREATMENT, INCLUDING ART, UNDER THE DOTS MODEL. 2. DEVELOP AND EXPAND ELECTRONIC DATA SYSTEMS FOR TRACKING DISEASES A MEMORANDUM OF UNDERSTANDING [MOU] HAS BEEN IN EXISTENCE FOR NEARLY THREE YEARS WITH BAOBAB HEALTH TRUST IN MALAWI TO BUILD ON AND EXPAND ON-GOING SYSTEMS FOR ART AND NON-COMMUNICABLE DISEASES, AND HAS BEEN RENEWED. BY SEPTEMBER 30TH, 2011, A TOTAL OF 145,352 ART PATIENTS HAD BEEN REGISTERED AT 17 GOVERNMENT CLINICS THROUGH THE ELECTRONIC MEDICAL RECORD SYSTEMS (EMR), AND 76,799 WERE ALIVE AND RETAINED ON THERAPY IN THESE CLINICS. AN EMR HAS BEEN DEVELOPED AND SET UP TO TRACK DIABETES PATIENTS IN TWO CENTRAL HOSPITALS IN BLANTYRE AND LILONGWE, USING THE DOTS MODEL AS THE MONITORING PLATFORM. THIS SYSTEM WENT "LIVE" IN BLANTYRE AT THE END OF 2009, AND BY SEPTEMBER 30TH, 2011, THERE WERE 2,210 DM PATIENTS ENTERED TO THE SYSTEM (SEE ABOVE). THE PLATFORM IS NOW BEING SET UP IN LILONGWE. BY SEPT. 30TH, 2011, A CUMULATIVE TOTAL OF 147,562 PATIENTS WITH HIV/AIDS OR DM WERE MONITORED UNDER EMR. 3. ENHANCE OPERATIONAL RESEARCH: COLLABORATIONS FOR OPERATIONAL RESEARCH: MOUS HAVE BEEN RENEWED AND ARE ACTIVE WITH A) MSF-BELGIUM FOR OPERATIONAL RESEARCH CAPACITY BUILDING AND FOR CONDUCTING OPERATIONAL RESEARCH, B) THE DESMOND TUTU TB CENTRE IN CAPE TOWN, SOUTH AFRICA, FOR OPERATIONAL RESEARCH WITHIN THE PROVINCE, AND C) DIGNITAS INTERNATIONAL IN ZOMBA DISTRICT, MALAWI, TO CONDUCT OPERATIONAL RESEARCH AND EXPAND USE OF VITAL REGISTRATION SYSTEMS. MOUS WITH AMPATH AND WITH PHFI OF INDIA HAVE RUN THEIR NATURAL COURSE. RESEARCH ACTIVITIES: SEVERAL RESEARCH ACTIVITIES ARE UNDERWAY, INCLUDING THE WRITING AND SUBMISSION OF REVIEW AND OPINION ARTICLES ABOUT OPERATIONAL RESEARCH AND INNOVATIVE IDEAS TO IMPROVE CASE MANAGEMENT OF DISEASE. OPERATIONAL RESEARCH TRAINING AND MARKETING: IN FEB. 2011, ADH DELIVERED THE "GEORGE COMSTOCK" PLENARY LECTURE AT NORTH AMERICAN IUATLD CONFERENCE IN VANCOUVER ON HOW OPERATIONAL RESEARCH CAN BE USED TO STRENGTHEN HIV AND TB CARE IN LOW-INCOME COUNTRIES. A SYMPOSIUM ON OPERATIONAL RESEARCH WAS HELD IN HONG KONG AT THE ASIA PACIFIC UNION REGIONAL CONFERENCE IN JULY 2011 AND AT THE WORLD LUNG HEALTH CONFERENCE IN LILLE IN OCT. 2011. OPERATIONAL RESEARCH COURSES: DETAILS ABOUT COMPLETED AND ON-GOING COURSES ARE PROVIDED IN ANNEX 1. IN SUMMARY, THERE HAVE BEEN 3 COMPLETED OPERATIONAL RESEARCH COURSES. THESE WERE ATTENDED BY 34 PARTICIPANTS, OF WHOM 31 (91%) COMPLETED ALL MILESTONES. A TOTAL OF 35 PAPERS WERE SUBMITTED TO PEER-REVIEW JOURNALS, OF WHICH 25 ARE IN PRESS OR PUBLISHED BY DEC 31ST 2011. OPERATIONAL RESEARCH FELLOWS: SIX WERE APPOINTED IN THE FIRST TWO YEARS: FROM VIETNAM, MALAWI, INDIA, SOUTH AFRICA, ZIMBABWE AND BRAZIL- HOWEVER, THE FELLOW FROM BRAZIL HAS MOVED TO ACADEMIA. THERE ARE FOUR OTHER RESEARCH FELLOWS APPOINTED THROUGH MOUS WITH THE DTTC IN CAPE TOWN AND AMPATH IN KENYA. SINCE THE START OF THE FELLOWSHIP PROGRAMME, THERE HAVE BEEN 55 RESEARCH PROJECTS: 39 PROJECTS HAVE BEEN COMPLETED AND PAPERS WRITTEN AND SUBMITTED FOR PUBLICATION IN PEER REVIEW JOURNALS OF WHICH 30 WERE PUBLISHED OR IN PRESS BY DECEMBER 31ST, 2011. THESE ARE SPECIFIED IN ANNEX 2. OPERATIONAL RESEARCH AND OPINION/REVIEW PROJECTS: BETWEEN JANUARY 1ST AND DECEMBER 31ST, 2011, THERE WERE 69 PUBLICATIONS FROM THE CENTRE, WHICH ARE SPECIFIED IN ANNEX 3: 44 RESEARCH PAPERS, 23 OPINION/REVIEW PAPERS AND 2 CONTRIBUTIONS TO INTERNATIONAL DOCUMENTS. 4. ENHANCE AND STRENGTHEN VITAL REGISTRATION SYSTEMS: INFORMATION GAINED IN HOW VITAL REGISTRATION SYSTEMS WORK WAS WRITTEN UP INTO A CONCEPT PAPER AND PUBLISHED IN THE TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE &amp; HYGIENE. A PAPER WAS ALSO PUBLISHED IN THE JOURNAL OF THE INTERNATIONAL AIDS SOCIETY FROM HARARE AND BULAWAYO, ZIMBABWE, ON THE USE OF ROUTINE CITY COUNCIL DATA TO CAPTURE 30 YEARS OF CRUDE AND SEX- AND AGE-SPECIFIC MORTALITY DATA. WE ARE PILOTING THE USE OF VILLAGE REGISTERS TO MONITOR VITAL REGISTRATION STATISTICS IN ZOMBA DISTRICT, MALAWI [POPULATION 670,000, 1460 TRADITIONAL VILLAGE HEADMEN EACH WITH A VILLAGE REGISTER]. WORK IS ON-GOING IN ONE TRADITIONAL AUTHORITY WITH 325 VILLAGE HEADMEN TO ASCERTAIN ACCURACY AND REPORTING SYSTEMS ASSOCIATED WITH THESE REGISTERS. WE HAVE RECOGNISED THAT TRANSFER OF DATA WITH PAPER-BASED SYSTEMS WILL BE VERY DIFFICULT. 5. TRACK THE ROLE OF OPERATIONAL RESEARCH TO CHANGE POLICY AND PRACTICE: LINKAGES HAVE BEEN FORMED WITH THE RESEARCH UNIT OF THE STOP-TB DEPARTMENT OF WHO ABOUT HOW TO TRANSLATE AND TRACK RESEARCH TO POLICY AND PRACTICE. A CONCEPT PAPER ON THIS SUBJECT WRITTEN WITH VARIOUS PARTNERS (MSF, WHO, CDC, GF) IS IN PRESS WITH LANCET INFECTIOUS DISEASES. ANNEX 4 PROVIDES SOME INFORMATION ABOUT HOW THE PUBLICATIONS FROM THE CENTRE IN 2011 HAVE INFLUENCED POLICY AND PRACTICE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>PROGRAM SERVICE STATEMENT</Identifier>
        <ReturnReference>FORM 990, PART III, LINE 4C</ReturnReference>
        <Explanation>6. TO COLLABORATE WITH WHO AND OTHER INTERNATIONAL ORGANIZATIONS: WORLD HEALTH ORGANIZATION (WHO): ADH SITS ON THE TB-HIV MONITORING AND ADVISORY GROUP, THE TB TREATMENT GUIDELINE WRITING GROUP, THE TB-HIV POLICY WRITING GROUP, THE EXPERT ADVISORY PANEL ON TUBERCULOSIS AND CHAIRS THE HIV STRATEGIC AND TECHNICAL ADVISORY COMMITTEE. THE STOP TB DEPARTMENT OF WHO HAS ALSO DEVELOPED A RESEARCH UNIT WITH WHICH THE CENTRE IS A STRONG COLLABORATOR. THE CENTRE AND THE UNION HAS WORKED WITH THE STOP TB DEPARTMENT OF WHO TO DEVELOP A GUIDELINE ON OPERATIONAL RESEARCH PRIORITIES FOR GLOBAL TB CONTROL, A ROAD MAP FOR TB RESEARCH AND A GLOBAL FRAMEWORK TO REDUCE THE JOINT BURDEN OF DM AND TB. WORLD DIABETES FOUNDATION (WDF): GOOD COLLABORATION EXISTS BETWEEN THE UNION AND WDF AND WHO. A GLOBAL WHO/UNION FRAMEWORK ON REDUCING THE JOINT BURDEN OF DM AND TB WAS LAUNCHED IN AUGUST 2011. THE UNION IS PART OF A CONSORTIUM THAT HAS APPROACHED THE EUROPEAN UNION FOR RESEARCH FUNDING AND SUPPORT IN THIS AREA: THE PHASE 1 PROPOSAL WAS ACCEPTED AND THE CONSORTIUM IS CURRENTLY DEVELOPING THE PHASE-2 PROPOSAL. THE UNION'S PROPOSAL TO WDF TO UNDERTAKE BI-DIRECTIONAL SCREENING OF TB AND DM IN CHINA AND INDIA WAS ACCEPTED IN MAY. IN BOTH CHINA AND INDIA, WORK HAS ALREADY STARTED: NATIONAL STAKEHOLDER MEETINGS HAVE BEEN HELD AND THE TRAINING MODULES COMPLETED: BI-DIRECTIONAL SCREENING HAS STARTED IN CHINA AND WILL START IN INDIA IN 2012. INTERNATIONAL AIDS SOCIETY: A GOOD COLLABORATION HAS BEEN FORMED WITH THE INTERNATIONAL AIDS SOCIETY IN TERMS OF BUILDING OPERATIONAL RESEARCH CAPACITY. THE UNION AND MSF WERE GUEST EDITORS FOR A SUPPLEMENT ON AIDS-RELATED OPERATIONAL RESEARCH IN THE JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (JIADS): 7 ARTICLES WERE PUBLISHED IN JULY. 7. SUPPORT THE CENTRE FOR STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH: THE CENTRE COMMENCED OPERATIONS ON JANUARY 1ST 2009. THE ADMINISTRATIVE STRUCTURE WAS SET UP WITHIN THE FIRST MONTH WITH THE APPOINTMENT OF DIRECTOR (AD HARRIES), DEPUTY DIRECTOR (KAREN BISSELL), PROJECT ADMINISTRATOR (SELMA DAR BERGER), PART-TIME ADMINISTRATIVE ASSISTANT (NATHALIE GUILLERM) AND PART-TIME TRAINING COURSE ADMINISTRATOR (CECILE SEVEL). THE FIRST TWO YEARS OF OPERATIONS FINISHED ON DECEMBER 31ST 2010. A NEW 2-YEAR PLAN WAS DEVELOPED FOR 2011-2012, AND FUNDING ARRIVED IN AUGUST 2011. ACTIVITIES HOWEVER, CONTINUED UNINTERRUPTED FROM JANUARY 1ST 2011. SKYPE CONFERENCE CALLS TAKE PLACE EVERY 3- 4 WEEKS BOTH INTERNALLY AND BETWEEN PARTNERS AND THE CENTRE AS A MEANS OF AGREEING TO THE WAY FORWARD AND TRACKING PROGRESS IN THE ANNUAL PLAN. QUARTERLY REPORTS CONTINUE TO BE SUBMITTED ON TIME EVERY THREE MONTHS. DURING OCTOBER TO DECEMBER 201, THE UK DEPARTMENT FOR INTERNATIONAL DEVELOPMENT (DFID) FINALISED THE TECHNICAL AND FINANCIAL ASPECTS OF SUPPORT FOR OPERATIONAL RESEARCH AND OPERATIONAL RESEARCH CAPACITY BUILDING. SUPPORT COMMENCED IN THE FOURTH QUARTER. 4. IMDP TRAINING PROGRAM AND CAPACITY BUILDING IN 2004, IUATLD, INC. LAUNCHED THE INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM (IMDP), WHICH AIMS TO TRAIN HEALTH MANAGERS WORLDWIDE AND PREPARE THEM TO POTENTIALLY ASSUME THE DIFFICULT TASK OF WELL MANAGING THEIR NATIONAL HEALTH PROGRAMS. IMDP MISSION IS TO DEVELOP A COMMUNITY OF LEADERS AND INNOVATORS WHO WILL MAKE A LASTING IMPACT IN IMPROVING THE QUALITY OF PRODUCTS AND SERVICES PROVIDED THROUGH THE PUBLIC HEALTH SECTOR. IN ADDITION TO THE COURSES, IMDP OFFERS TO ITS ALUMNI CONTINUING LEARNING THROUGH THE HEALTH MANAGER, AN ONLINE RECURRING PUBLICATION THAT FOCUSES ON MANAGEMENT EDUCATION, SPECIFICALLY FOR HEALTH PROFESSIONALS. IN 2011, THE UNION'S INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM (IMDP) TRAINED CLOSE TO 600 PARTICIPANTS FROM OVER 40 COUNTRIES. PROFESSIONALS SPECIALIZING IN A VARIETY OF HEALTH FIELDS ATTENDED 29 COURSES HELD THROUGHOUT THE YEAR TO DEVELOP THEIR EXISTING SKILLS AND GAIN NEW ONES TO HELP IMPROVE THE QUALITY OF HEALTH SERVICES PROVIDED BY THE ORGANIZATIONS WHERE THEY WORK. DURING 2011, PARTICIPANTS WERE TRAINED IN THE FOLLOWING AREAS: BUDGETING AND FINANCE PROJECT MANAGEMENT LEADERSHIP COMMUNICATIONS AND MASS MEDIA STRATEGIC PLANNING DRUG-SUPPLY MANAGEMENT HUMAN RESOURCES PARTNERSHIP BUILDING COURSES TOOK PLACE IN 10 COUNTRIES INCLUDING MALAYSIA, MEXICO, EGYPT, CHINA, INDONESIA, SINGAPORE, BANGLADESH, INDIA, ZIMBABWE, AND THAILAND. PARTICIPANTS WERE OFFERED THE UNIQUE EXPERIENCE OF NETWORKING, SHARING EXPERIENCES AND LEARNING FROM HEALTH PROFESSIONALS IN SIMILAR FIELDS FROM AROUND THE WORLD. DR NATALIA CELAURO FROM PARAGUAY, WHO WORKS IN TOBACCO CONTROL, HAD THIS TO SAY ABOUT HER IMDP EXPERIENCE: "THIS TRANSFER OF KNOWLEDGE GAVE US THE OPPORTUNITY TO IMPLEMENT OTHER SUCCESSFUL PROJECTS AND ADAPT THEM TO OUR CONTEXT. ALSO, IT IS IMPORTANT TO KNOW THE LARGER PROCESS OF WORKING IN TOBACCO CONTROL, NOT ONLY IN MY COUNTRY, BUT ALSO ON A REGIONAL LEVEL." THE IMDP CONTINUED TO EXPAND ITS ONLINE EDUCATIONAL OPPORTUNITIES IN 2011 WITH THE LAUNCH OF THE HEALTH MANAGER, AN ONLINE PUBLICATION THAT FOCUSES ON MANAGEMENT EDUCATION FOR HEALTH PROFESSIONALS. EACH ISSUE ADDRESSES ONE ASPECT OF MANAGING A HEALTH ORGANIZATION, SUCH AS PUTTING TOGETHER A BUDGET FOR A GRANT OR PROJECT, MANAGING A NATIONAL DRUG PROGRAM OR DEVELOPING A STRATEGIC PLAN. INSIGHTS FROM EXECUTIVES WITH LONG EXPERIENCE IN MANAGING PUBLIC HEALTH ORGANIZATIONS ARE ALSO FEATURED. THE HEALTH MANAGER IS AVAILABLE TO THE PUBLIC AT NO CHARGE AND MAY BE FOUND ON BOTH THE UNION AND IMDP WEBSITES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 2</ReturnReference>
        <Explanation>MR. PETER BALDINI, MR JOSE LUIS CASTRO, PAULA I.FUJIWARA AND MR. NILS BILLO HAVE A BUSINESS RELATIONSHIP. ALL OF THESE PERSONS SERVE IN DIFFERENT CAPACITIES ON THE BOARDS OF RELATED ORGANIZATIONS. MR BILLO ALSO SERVES AS THE EXECUTIVE DIRECTOR IUATLD, INC, PARIS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 8B</ReturnReference>
        <Explanation>IUATLD, INC. HAD NO SUB-COMMITTEES OF THE BOARD IN 2010. THE GOVERNING BODY MADE ALL DECISIONS, INCLUDING ASSUMING THE RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. IN JANUARY 2011, HOWEVER, THE ORGANIZATION FORMED AN AUDIT COMMITTEE WITH MEMBERSHIP FROM THE BOARD. THE AUDIT COMMITTEE REVIEW THE ANNUAL AUDITS, FINANCIAL STATEMENTS AND TAX RETURNS, AND OVERSEE THE SELECTION OF AN INDEPENDENT ACCOUNTANT. AUDIT COMMITTEE RECOMMENDATIONS ARE PRESENTED TO THE FULL BOARD FOR REVIEW AND APPROVAL.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 11</ReturnReference>
        <Explanation>IUATLD, INC. HAS ITS FORM 990 PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. WHEN THE FORM 990 HAS BEEN PREPARED, REVIEW BY MANAGEMENT AND IS READY TO FILED WITH THE INTERNAL REVENUE SERVICE, IT IS SUBMITTED ELECTRONICALLY TO MEMBERS OF THE IUATLD, INC. BOARD OF DIRECTORS FOR ANY COMMENTS PRIOR TO ITS SUBMISSION. THE BOARD OF DIRECTORS IS PROVIDED ONE WEEK TO REVIEW THE PREPARED FORM 990, TO CONSULT WITH MANAGEMENT, AND TO PROVIDE THEIR COMMENTS. ANY COMMENTS RECEIVED ARE THEN GROUPED, SUMMARIZED AND PROVIDED TO THE COMMITTEE IN CHARGE OF FILING THE RETURN FOR THEIR REVIEW AND ACTION. EACH ISSUE IS DOCUMENTED AND ADDRESSED UNTIL THE RETURN IS FINALIZED AND APPROVED FOR FILING.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 12C</ReturnReference>
        <Explanation>IUATLD, INC. HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT ANNUALLY MONITORS AND ENFORCES. THE BOARD OF DIRECTORS MANDATES THAT ALL MEMBERS OF MANAGEMENT AND THE GOVERNING BODY ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED POLICIES ARE SUBMITTED TO THE EXECUTIVE DIRECTOR (WHO CURRENTLY SERVES AS THE ORGANIZATION'S COMPLIANCE OFFICER) WHO REVIEWS THE SIGNED ATTESTATIONS FOR POTENTIAL OR ACTUAL CONFLICTS. (IN THE ABSENCE OF A DEDICATED COMPLIANCE OFFICER, THE PRESIDENT OF THE BOARD OF DIRECTORS CURRENTLY PERFORMS THIS FUNCTION FOR THE POLICY SUBMITTED BY THE EXECUTIVE DIRECTOR). IF POTENTIAL OR ACTUAL CONFLICTS OF INTEREST EXIST, PROPER NOTIFICATIONS ARE MADE, AND RESULTS OF INVESTIGATIONS ARE SUMMARIZED AND REPORTED TO THE BOARD OF DIRECTORS. IF ACTUAL CONFLICTS EXIST, THE INDIVIDUAL(S) INVOLVED ARE NOT ALLOWED TO VOTE OR BE A PART OF ANY DECISIONS ABOUT ANY SUCH TRANSACTIONS THAT RELATE TO THE CONFLICT UNTIL SUCH TIME AS THERE IS NO LONGER A CONFLICT.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 15</ReturnReference>
        <Explanation>IUATLD, INC. HAS ESTABLISHED A WRITTEN COMPENSATION POLICY TO BE FOLLOWED BY MANAGEMENT AND, WHEN NECESSARY, THE BOARD OF DIRECTORS IN ORDER TO ESTABLISH THE COMPENSATION FOR THE EXECUTIVE DIRECTOR AND OTHER KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE-LEVEL COMPENSATION BE PERIODICALLY REVIEWED BY MANAGEMENT AND THE BOARD OF DIRECTORS AND THAT THE REVIEW PROCESS SHOULD BE FREE OF POTENTIAL CONFLICTS OF INTEREST. THE APPROVING ENTITY NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF COMPENSATION BEING CONSIDERED. A VARIETY OF INFORMATION AND COMPARABILITY DATA ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO EXECUTIVES. THESE INCLUDE SURVEYS OF NEW YORK CITY-BASED NON-PROFIT COMPENSATION PRACTICES, COMPARABLE PACKAGES FOR KEY STAFF OF PEER ORGANIZATIONS, AND COMPENSATION PRACTICES EXPECTED BY PROJECT DONORS. DECISIONS TAKEN ON COMPENSATION LEVELS TO BE PAID MUST BE DOCUMENTED IN WRITTEN FORM TO INCLUDE THE DATES DECISIONS ARE TAKEN, THE PARTIES PRESENT DURING THE DECISION, THE FULL TERMS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. THE COMPENSATION REVIEW PROCESS FOR THE EXECUTIVE DIRECTOR AND SENIOR ADVISOR POSITIONS WAS UNDERTAKEN IN JANUARY 2009. THE EXECUTIVE DIRECTOR'S COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS IN ADDITION TO THE ONES DESCRIBED ABOVE, INCLUDING COMPARABLE COMPENSATION LEVELS FOR A) NEW YORK CITY-BASED EXECUTIVES OVERSEEING NOT FOR PROFIT ORGANIZATIONS AND AFFILIATE OFFICES OF INTERNATIONAL ORGANIZATIONS, B) PUBLIC HEALTH PROFESSIONALS WITH 15-20 YEARS EXPERIENCE IN PROJECT MANAGEMENT, PARTNERSHIPS AND OPERATIONS AND LASTLY THE SALARY EXPECTATIONS OF KEY DONORS TO IUATLD, INC.-COORDINATED PROJECTS. THE SENIOR ADVISORS COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS INCLUDING COMPARABLE COMPENSATION LEVELS FOR U.S. BASED MEDICAL DOCTORS WHO A) HAVE A VERY HIGH LEVEL OF CLINICAL EXPERIENCE IN THE TREATMENT, CONTROL AND PREVENTION OF TUBERCULOSIS AND HIV/AIDS, B) HAVE AT LEAST TWENTY YEARS OF EXPERIENCE IN MANAGING COMPLEX PUBLIC HEALTH PROGRAMS, INTERNATIONAL RESEARCH PROJECTS AND INTERNATIONAL TECHNICAL ASSISTANCE PROJECTS IN DEVELOPING COUNTRY SETTINGS AND C) HAVE DEEP EXPERIENCE IN WORKING WITH U.S. GOVERNMENT TECHNICAL AGENCIES AND DONORS INVOLVED IN GLOBAL LUNG HEALTH INITIATIVES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 19</ReturnReference>
        <Explanation>IUATLD, INC. MAKES ITS FORM 990 AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE SERVICE CODE BY POSTING IT TO GUIDESTAR AND OTHER SIMILAR TYPES OF WEBSITES. IN ADDITION, ALL FORMS 990, AS WELL AS FINANCIAL STATEMENTS, THE CONFLICT OF INTEREST POLICY AND OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST AT IUATLD, INC. OFFICES LOCATED AT 61 BROADWAY, SUITE 1720, NEW YORK, NY 10006 OR BY CALLING THE ORGANIZATION DIRECTLY AT (212) 500-5720.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>HOURS OF BOARD SERVICE TO RELATED ORGANIZATIONS</Identifier>
        <ReturnReference>FORM 990, PART VII, SECTION A, COLUMN A &amp; B</ReturnReference>
        <Explanation>THE FILING ORGANIZATION, THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC., AND THEIR RELATED ORGANIZATION, WORLD LUNG FOUNDATION, HAVE SIMILAR INDIVIDUALS, MENTIONED BELOW, SERVING ON THEIR BOARDS: JOSE LUIS CASTRO, BOARD PRESIDENT OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. ALSO SERVES AS A BOARD MEMBER OF THE WORLD LUNG FOUNDATION. HOURS SERVED, DEVOTED TO THESE POSITIONS, WAS 10.0 HOURS/WEEK FOR THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC., AND 40 HOURS/WEEK FOR THE WORLD LUNG FOUNDATION. PETER BALDINI, BOARD MEMBER OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. ALSO SERVES AS BOARD MEMBER AND CEO OF THE WORLD LUNG FOUNDATION. HOURS SERVED, DEVOTED TO THESE POSITIONS, WAS 1.0 HOUR/WEEK FOR THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC., AND 40 HOURS/WEEK FOR THE WORLD LUNG FOUNDATION. NILLS E. BILLO, BOARD MEMBER OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. ALSO SERVES AS BOARD SECRETARY OF THE WORLD LUNG FOUNDATION. HOURS SERVED, DEVOTED TO THESE POSITIONS, WAS 1.0 HOUR/WEEK FOR THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC., AND 3.0 HOURS/WEEK FOR THE WORLD LUNG FOUNDATION. PAULA I. FUJIWARA, SENIOR ADVISOR OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. ALSO SERVES AS BOARD MEMBER OF THE WORLD LUNG FOUNDATION. HOURS SERVED, DEVOTED TO THESE POSITIONS, WAS 4.0 HOUR/WEEK FOR THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC., AND 3.0 HOURS/WEEK FOR THE WORLD LUNG FOUNDATION.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>OVERSIGHT OF THE AUDIT OF THE FINANCIAL STATEMENTS AND ACCOUNTANT SELECTION</Identifier>
        <ReturnReference>FORM 990, PART XI, LINE 2C:</ReturnReference>
        <Explanation>THIS PROCESS DID NOT CHANGE FROM THE PRIOR YEAR. ALTHOUGH, IUATLD, INC. DOES NOT HAVE ANY AUDIT COMMITTEE, THE GOVERNING BODY ACTS IN THAT CAPACITY AND MAKES ALL DECISIONS.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <Form990ScheduleRPartII>
        <NameOfDisregardedEntity>
          <BusinessNameLine1>WORLD LUNG FOUNDATION</BusinessNameLine1>
        </NameOfDisregardedEntity>
        <AddressUS>
          <AddressLine1>61 BROADWAY</AddressLine1>
          <City>NEW YORK</City>
          <State>NY</State>
          <ZIPCode>10006</ZIPCode>
        </AddressUS>
        <EIN>202432410</EIN>
        <PrimaryActivities>TOBACCO REDUCTION/HEALTH RESEARCH INITIATIVE</PrimaryActivities>
        <LegalDomicileState>NY</LegalDomicileState>
        <ExemptCodeSection>501(C)(3)</ExemptCodeSection>
        <PublicCharityStatus>509(A)(3)</PublicCharityStatus>
        <DirectControllingEntityName>
          <BusinessNameLine1>INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE INC</BusinessNameLine1>
        </DirectControllingEntityName>
        <ControlledOrg>1</ControlledOrg>
      </Form990ScheduleRPartII>
      <ReceiptOfIntAnnRentsRoyalties>0</ReceiptOfIntAnnRentsRoyalties>
      <GiftGrantOrCapContrToOtherOrg>0</GiftGrantOrCapContrToOtherOrg>
      <GiftGrantOrCapContrFrOtherOrg>1</GiftGrantOrCapContrFrOtherOrg>
      <LoansOrGuaranteesToOtherOrg>0</LoansOrGuaranteesToOtherOrg>
      <LoansOrGuaranteesFromOtherOrg>0</LoansOrGuaranteesFromOtherOrg>
      <SaleOfAssetsToOtherOrg>0</SaleOfAssetsToOtherOrg>
      <PurchaseOfAssetsFromOtherOrg>0</PurchaseOfAssetsFromOtherOrg>
      <ExchangeOfAssets>0</ExchangeOfAssets>
      <RentalOfFacilitiesToOtherOrgs>0</RentalOfFacilitiesToOtherOrgs>
      <RentalOfFacilitiesFrOtherOrgs>0</RentalOfFacilitiesFrOtherOrgs>
      <PerformOfServicesForOtherOrgs>0</PerformOfServicesForOtherOrgs>
      <PerformOfServicesByOtherOrgs>0</PerformOfServicesByOtherOrgs>
      <SharingOfFacilities>0</SharingOfFacilities>
      <SharingOfPaidEmployees>1</SharingOfPaidEmployees>
      <ReimbursementPaidToOtherOrg>0</ReimbursementPaidToOtherOrg>
      <ReimbursementPaidByOtherOrg>0</ReimbursementPaidByOtherOrg>
      <OtherTransferToOtherOrg>0</OtherTransferToOtherOrg>
      <OtherTransferFromOtherOrg>0</OtherTransferFromOtherOrg>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>WORLD LUNG FOUNDATION</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>N</TransactionType>
        <AmountInvolved>345380</AmountInvolved>
        <MethodOfAmtDetermination>COST</MethodOfAmtDetermination>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>WORLD LUNG FOUNDATION</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>C</TransactionType>
        <AmountInvolved>18739184</AmountInvolved>
        <MethodOfAmtDetermination>CASH</MethodOfAmtDetermination>
      </TransactionsRelatedOrgsTable>
    </IRS990ScheduleR>
    <ReasonableCauseExplanation documentId="RetDoc2125800001">
      <Explanation>RETURN FILING EXTENDED TO FEB. 1, 2013INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. HAS MADE A DECLARATION WITH THE IRS TO POSTPONE THE FILING OF ITS TAX RETURN ON OR BEFORE FEB. 1, 2013 DUE TO THE EFFECTS OF HURRICANE SANDY. THE IRS'S HURRICANE SANDY TAX RELIEF POSTPONES VARIOUS TAX FILINGS AND PAYMENTS NORMALLY DUE DURING OCTOBER 31, 2012 AND JAN. 31, 2012. AS SUCH, PLEASE ACCEPT OUR TAX RETURN AS BEING PROPERLY FILED.</Explanation>
    </ReasonableCauseExplanation>
  </ReturnData>
</Return>